KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 72 filers reported holding KALA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $39,000 | +2.6% | 28,161 | -10.0% | 0.00% | – |
Q4 2021 | $38,000 | -51.3% | 31,283 | +5.2% | 0.00% | – |
Q3 2021 | $78,000 | -95.5% | 29,727 | -91.0% | 0.00% | -100.0% |
Q2 2021 | $1,752,000 | -20.7% | 330,617 | +0.9% | 0.00% | 0.0% |
Q1 2021 | $2,208,000 | +982.4% | 327,604 | +991.6% | 0.00% | – |
Q4 2020 | $204,000 | +21.4% | 30,010 | +33.3% | 0.00% | – |
Q3 2020 | $168,000 | -63.0% | 22,506 | -48.0% | 0.00% | – |
Q2 2020 | $454,000 | +558.0% | 43,312 | +454.1% | 0.00% | – |
Q1 2020 | $69,000 | +146.4% | 7,817 | +0.7% | 0.00% | – |
Q4 2019 | $28,000 | +33.3% | 7,761 | +33.9% | 0.00% | – |
Q3 2019 | $21,000 | -78.4% | 5,796 | -62.6% | 0.00% | – |
Q2 2019 | $97,000 | -34.0% | 15,490 | -13.9% | 0.00% | – |
Q1 2019 | $147,000 | -88.8% | 17,993 | -93.3% | 0.00% | -100.0% |
Q4 2018 | $1,310,000 | +5.5% | 268,054 | +113.0% | 0.00% | – |
Q3 2018 | $1,242,000 | +71.1% | 125,839 | +137.9% | 0.00% | – |
Q2 2018 | $726,000 | +107.4% | 52,897 | +138.7% | 0.00% | – |
Q1 2018 | $350,000 | -0.6% | 22,165 | +16.1% | 0.00% | – |
Q4 2017 | $352,000 | +84.3% | 19,096 | +126.1% | 0.00% | – |
Q3 2017 | $191,000 | – | 8,445 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 771,790 | $5,788,000 | 5.46% |
RA Capital Management | 10,874,613 | $81,560,000 | 1.49% |
Mesirow Financial Investment Management, Inc. | 36,445 | $273,000 | 1.17% |
Samsara BioCapital, LLC | 451,162 | $3,384,000 | 0.94% |
Parkman Healthcare Partners LLC | 310,053 | $2,325,000 | 0.62% |
Orbimed Advisors | 5,465,030 | $40,988,000 | 0.52% |
Eventide Asset Management | 3,450,000 | $25,875,000 | 0.51% |
Vivo Capital, LLC | 786,883 | $5,902,000 | 0.34% |
Ikarian Capital, LLC | 451,531 | $3,387,000 | 0.24% |
Matisse Capital | 50,300 | $377,000 | 0.15% |